Ginkgo Bioworks Holdings, Inc. acquires Zymergen Inc. (2022)

Deal facts

Buyer: Ginkgo Bioworks Holdings, Inc.
Target: Zymergen Inc.
Deal value: Not disclosed
Announced: 19 October 2022
Status: Completed
Sector: Other
Country: United States
Consideration: shares

Sources

SEC_EDGAR_8K

What we know

Weekly digest

Join Exit Mode Insider

Ten deal briefs a week, founder commentary, and the patterns worth paying attention to.

Join Exit Mode Insider, £12/mo

Deal timeline

1 update

19 Oct 2022CompletedClosed
Ginkgo Bioworks Holdings, Inc. completes acquisition of Zymergen Inc.
Introductory Note On October 19, 2022, Ginkgo Bioworks Holdings, Inc., a Delaware corporation (“Parent”), completed the previously announced acquisition of Zymergen Inc., a Delaware public benefit corporation (“Zymergen” or the “Company”), pursuant to the Agreement and Plan of Merger, dated as of July 24, 2022 (the “Merger Agreement”), by and among the Company, Parent and Pepper Merger Subsidiary
Source

OpinionExit Mode editorial

We see a clear signal in the transaction where Ginkgo Bioworks Holdings, Inc. acquired Zymergen Inc. in October 2022. This was not a standard cash buyout but a going-private deal structured entirely through the exchange of shares. The announcement date marks a pivotal moment for the synthetic biology sector, yet the mechanics here demand closer inspection by the SME founder reading this. When a deal is priced solely in shares, the value proposition shifts from immediate liquidity to a long-term bet on the combined entity. This structure often implies that the buyer believes the target is undervalued in public markets or that the acquirer needs to preserve cash for integration.

The absence of a stated monetary value in the public record is typical for share-swap arrangements, where the final price depends on the relative share prices at completion. For a founder, this introduces a specific commercial risk: the dilution of ownership and the volatility of the new holding company. Unlike a cash deal where the exit is final, a share-based going-private transaction leaves the founder exposed to the post-close performance of the merged group. While this deal crossed the Atlantic with both parties based in the US, the regulatory context for such a consolidation would typically involve a CMA review if the UK nexus existed, or standard anti-trust thresholds in the US. The fact that the deal completed suggests regulatory clearance was obtained without major hurdles, a critical success factor for any founder considering a similar path.

We must also consider the change-of-control covenants that likely triggered upon announcement. In a going-private scenario, existing debt agreements often require immediate repayment or renegotiation. The reliance on shares as the sole consideration type means the target company's shareholders effectively become minority stakeholders in a larger, private entity. This is a stark departure from the traditional M&A exit where founders walk away with cash and a clean break. The strategic logic here points to consolidation within a niche sector, aiming to create a dominant platform rather than a simple acquisition of technology.

Your immediate action this week is to review your current shareholder agreements and debt covenants to identify any change-of-control triggers that could be activated by a share-swap offer. Do not wait for a term sheet to understand how a non-cash consideration might alter your liquidity position or lock you into a new, longer-term holding structure.

Editorial opinion. Not financial or legal advice.

Explore

Browse adjacent archives

Jump from this deal into the sector, buyer, deal type, and year views that carry the strongest contextual signal.

More Other deals More 2022 deals More going private deals More from Ginkgo Bioworks Holdings, Inc.All M&A deals

Similar deals

Other Other M&A activity tracked by Exit Mode.

9 May 2026Firm intentionOther

Emma Buyer, LLC to acquire Emerald Holding, Inc.

Emma Buyer, LLC and Emerald Holding, Inc. entered the Exit Mode archive.

Buyer: Emma Buyer, LLC
Target: Emerald Holding, Inc.
Deal value: Not disclosed
Deal type: going private

Read deal Other deals going private deals United States deals

6 April 2026CompletedOther

RWAY to acquire SWK Holdings Corp

RWAY and SWK Holdings Corp entered the Exit Mode archive.

Buyer: RWAY
Target: SWK Holdings Corp
Deal value: USD 244,352,684.96
Deal type: going private

Read deal Other deals going private deals United States deals

27 March 2026Firm intentionOther

Ikigai Ventures Limited to acquire Dotlines Global Limited

Ikigai Ventures Limited and Dotlines Global Limited entered the Exit Mode archive.

Buyer: Ikigai Ventures Limited
Target: Dotlines Global Limited
Deal value: Not disclosed
Deal type: going private

Read deal Other deals going private deals Announced deals

10 March 2026CompletedOther

Bending Spoons S.p.A to acquire Eventbrite, Inc.

Bending Spoons S.p.A and Eventbrite, Inc. entered the Exit Mode archive.

Buyer: Bending Spoons S.p.A
Target: Eventbrite, Inc.
Deal value: USD 4.5
Deal type: going private

Read deal Other deals going private deals United States deals

6 February 2026CompletedOther

SPX Enterprises, LLC to acquire Crawford United Corporation

SPX Enterprises, LLC and Crawford United Corporation entered the Exit Mode archive.

Buyer: SPX Enterprises, LLC
Target: Crawford United Corporation
Deal value: Not disclosed
Deal type: going private

Read deal Other deals going private deals United States deals

Buyer history